Midcap Value ETF Vanguard (VOE)
$95.31 0.22 (0.23%)
20:00 EDT VOE Stock Quote Delayed 30 Minutes
Previous Close $95.31
Market Cap 7.24B
PE Ratio -
Volume (Avg. Vol.) 393,300
Day's Range 94.09 - 95.90
52-Week Range 67.66 - 122.20
Dividend & Yield 2.50 (2.62%)
VOE Stock Predictions, Articles, and Midcap Value ETF Vanguard News
- From InvestorPlace
- From the Web
Vanguard ETFs are popular with advisors and investors due to its reputation for having some of the lowest fees in the fund industry.
A sophisticated collection of set-it-and-forget-it ETFs in your portfolio can help you to maximize returns without trading.
The stock market has experienced sell-off in the last couple of days stemmed from concerns over the delay in the implementation of corporate tax cuts.
Vanguard mid-cap stock ETFs offer investors a low-cost, diversified approach to capturing the "sweet spot" of U.S. market performance.
Vanguard ETFs are among the industry's least expensive, but finding the best Vanguard ETFs is about more than just picking the cheapest.
In today's mixed-up world of Central Bank planning bad news is good news. That can't be good for the market and investors
The Fed's decision to leave interest rates should've vaulted the market higher. It's time to get concerned over the next drop in the S&P 500
From The Motley Fool
From Simply Wall St
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, ‘The possibility of permanent loss is the risk I worry about… and every practical<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ino/inovio-pharmaceuticals/news/is-inovio-pharmaceuticals-nasdaqino-using-debt-in-a-risky-way/">Read More...</a></div>
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant